These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 480153)

  • 1. Physical characterization of solid iopanoic acid forms.
    Stagner WC; Guillory JK
    J Pharm Sci; 1979 Aug; 68(8):1005-9. PubMed ID: 480153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state properties of an oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its acetic acid solvate. I: Physicochemical characterization, intrinsic dissolution rate, and solution thermodynamics.
    Chan HK; Venkataram S; Grant DJ; Rahman YE
    J Pharm Sci; 1991 Jul; 80(7):677-85. PubMed ID: 1941568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization of the methanol solvate of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1989 Jan; 78(1):28-34. PubMed ID: 2709315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of phenylbutazone: properties and compressional behavior of crystals.
    Ibrahim HG; Pisano F; Bruno A
    J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
    Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
    Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical characterization of two oxyphenbutazone pseudopolymorphs.
    Stoltz M; Lötter AP; Van der Watt JG
    J Pharm Sci; 1988 Dec; 77(12):1047-9. PubMed ID: 3244109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine.
    Caira MR; Robbertse Y; Bergh JJ; Song M; De Villiers MM
    J Pharm Sci; 2003 Dec; 92(12):2519-33. PubMed ID: 14603498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside.
    Nguyen NA; Ghosh S; Gatlin LA; Grant DJ
    J Pharm Sci; 1994 Aug; 83(8):1116-23. PubMed ID: 7983595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of glybuzole polymorphs and their pharmaceutical properties.
    Otsuka M; Ofusa T; Matsuda Y
    Drug Dev Ind Pharm; 1999 Feb; 25(2):197-203. PubMed ID: 10065353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
    Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
    Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization of spray-dried phenylbutazone polymorphs.
    Matsuda Y; Kawaguchi S; Kobayashi H; Nishijo J
    J Pharm Sci; 1984 Feb; 73(2):173-9. PubMed ID: 6707878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
    Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
    J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and structural comparison of oxyphenbutazone monohydrate and anhydrate.
    Stoltz M; Caira MR; Lotter AP; van der Watt JG
    J Pharm Sci; 1989 Sep; 78(9):758-63. PubMed ID: 2585271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.